CHARLES MINARD to Rhabdomyosarcoma
This is a "connection" page, showing publications CHARLES MINARD has written about Rhabdomyosarcoma.
Connection Strength
0.348
-
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma. Cancer. 2023 07 15; 129(14):2245-2255.
Score: 0.177
-
A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412. Clin Cancer Res. 2022 12 01; 28(23):5088-5097.
Score: 0.172